Credit Suisse, Leerink Swann, BMO Capital and Wedbush PacGrow assist
By Devika Patel
Knoxville, Tenn., May 9 - Receptos, Inc. priced its $72.8 million initial public offering of stock with a $10.92 million greenshoe in a prospectus filed Thursday with the Securities and Exchange Commission. It expects the shares to trade on the Nasdaq under the symbol "RCPT." The deal was announced April 4.
The company will sell 5.2 million common shares at $14.00 apiece.
Credit Suisse, Leerink Swann, BMO Capital Markets and Wedbush PacGrow Life Sciences are assisting.
Settlement is expected May 14.
Proceeds will be used for clinical studies, in-house research activities, working capital and general corporate purposes.
The biopharmaceutical company is based in San Diego.
| Issuer: | Receptos, Inc.
|
| Issue: | Common stock
|
| Amount: | $72.8 million
|
| Greenshoe: | $10.92 million
|
| Shares: | 5.2 million
|
| Price: | $14.00
|
| Warrants: | No
|
| Announcement date: | April 4
|
| Pricing date: | May 9
|
| Settlement date: | May 14
|
| Stock exchange: | Nasdaq: RCPT
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
